British Biotech and MethylGene sign agreement on Phase II antisense drug.
Expert review of anticancer therapy
View on PubMed
Abstract & Figures
Sorry, we couldn't extract an abstract for this paper.
Sorry, we couldn't extract any citations for this paper.
Sorry, we couldn't extract any references for this paper.
Loading similar papers…
Presentations referencing similar topics